MedTrace Logo

Hybrid Ablation of Persistent and Long-standing Persistent Stand-alone Atrial Fibrillation

NCT02832206 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2021-08-09

No results posted yet for this study

Summary

This study evaluates in detail efficacy and safety (including neurological safety) of hybrid ablation of stand-alone, persistent and long-standing persistent atrial fibrillation (AF). An implantable ECG monitor will be implanted to all patients for rhythm monitoring. Neurological safety will be assessed by cerebral magnetic resonance, neuropsychological examination and periprocedural transcranial Doppler measurement.

Conditions

Interventions

PROCEDURE

hybrid ablation

Surgical thoracoscopic epicardial ablation (box-lesion) and left atrial appendage occlusion , followed (after 2-3months) by electrophysiological examination, and catheter ablation (completion of the box-lesion, cavotricuspid isthmus ablation and other ablation if indicated)

Sponsors & Collaborators

  • Charles University, Czech Republic

    lead OTHER

Principal Investigators

  • Zbynek Straka, MD, PhD · University Hospital Kralovske Vinohrady

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-01
Primary Completion
2019-12-10
Completion
2019-12-10

Countries

  • Czechia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02832206 on ClinicalTrials.gov